DAY 1 - LIVE SESSIONS

Question Title

* 1. Contact Information

Question Title

* 2. Professional Category

Question Title

* 3. Professional Practice Category

Question Title

* 4. Years of Experience

Session Evaluations
Please complete the evaluation for all of the sessions you attended/streamed.

Question Title

* 5. WEDNESDAY, MAY 26th, 2021 - LIVE Broadcast Sessions - CMLE Credits: 1.5 per session

The speakers’ level of expertise regarding content presented was:

  Excellent Very Good Good Fair Poor N/A
Plenary Session - COVID-19: Understanding the Path Forward for Mesenchymal Stromal Cell Therapies
MSC Session - MSC-Derived EVs: Cell Therapy without Cells
Commercialization Session - Allogeneic Therapies - What Really is a Healthy Donor?
MSC Session - Debating MSC Tissue Sources: Biological and Manufacturing Considerations
Commercialization Session - Naming Cell & Gene Therapies – Harmonizing with INN Nomenclature and Regulatory Impact – A Joint ISCT – WHO Session
Regulatory Session - The Path to a Biologics License Application (BLA)
Presidential Plenary - Integrating Science, Regulatory Oversight, and Commercialization for the New Wave of Cell and Gene Therapies
MSC Session - Understanding Regulatory Requirements for Potency Assays
Commercialization Session - The Economic Impact on Healthcare and the Future of Advanced Cell & Gene Therapy
MSC Session - Lessons & Recommendations for Clinical Trials of MSCs for Musculoskeletal Diseases in 2021
Commercialization Session - Advancing the Translational Process through Automation & Equipment that Deliver Successful Scale Up/ Out in Cell Therapies
Regulatory Session - Phishing for Cell Therapies – Therapeutic Deception

Question Title

* 6. Total Credits on Wednesday:

T